Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market
LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transaction, LifeVantage has acquired LoveBiome’s critical operating assets essential to the microbiome health business, including the retention of key LoveBiome personnel.
“We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Olsen and the LoveBiome team to accelerate growth by leveraging their innovative microbiome solutions with our proven Activation technologies as one LifeVantage,”
said Steve Fife, President and CEO of LifeVantage.
“This strategic transaction expands our product portfolio into the rapidly growing gut health market while also broadening our reach in key markets including the US, Taiwan, and Europe, underscoring our deep commitment to our mission of offering people around the world a better path to wellness through Activation.”
“We are excited to be part of LifeVantage and believe the partnership will allow us to achieve our aggressive growth plans,”
explained Kelly Olsen, founder and CEO of LoveBiome.
“By combining our innovative P84 product with LifeVantage’s proven